Overview

Study of DCR-AUD in Healthy Volunteers

Status:
Recruiting
Trial end date:
2022-09-10
Target enrollment:
Participant gender:
Summary
DCR-AUD will be evaluated for safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Dicerna Pharmaceuticals, Inc.
Collaborator:
Parexel